Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Guidewires Preshaped
Showing all 4 results
Cardiac Surgery Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 15 more
The global market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVr) devices, transcatheter aortic heart valve implantation (TAVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion (AD) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pump (IABP) devices, patent foramen ovale (PFO) devices, atrial and ventricular septal defect (ASD and VSD) devices, left atrial appendage closure (LAA) devices, preshaped guidewires and cerebral embolic protection devices.
more...TAVR/TAVI, Cerebral Embolic Protection, and Pre-Shaped Guidewire Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes 3 Reports
Global TAVI/TAVR, CEPD, and Pre-Shaped Guidewire markets are expected to increase to reach $8.4 billion, $492.3 million, and $70.9 million. The analysis includes in-depth procedure numbers, which will seemingly increase over the forecast period, along with the impact of COVID-19 on the procedure volume.
more...Cardiac Surgery Market Size, Share, and Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 22 more
Overall, the U.S. cardiac surgery market was valued at $8.4 billion in 2022. This is expected to increase over the forecast period at a CAGR of 6.1% to reach $12.7 billion. Currently, the U.S. cardiac surgery market is dominated by Edwards Lifesciences, Abbott, and Medtronic. Throughout this medical market research, we analyzed over 30 cardiac […]
more...Cardiac Surgery Market Size, Share, and COVID-19 Impact Analysis | Europe | 2020-2026 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 21 more
In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026. Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe […]
more...